These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 11523022)

  • 1. Cancer therapy. New strategies and treatment modalities for optimizing patient outcomes.
    Gabrilove JL
    Semin Hematol; 2001 Jul; 38(3 Suppl 7):1-7. PubMed ID: 11523022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epoetin alfa therapy increases hemoglobin levels and improves quality of life in patients with cancer-related anemia who are not receiving chemotherapy and patients with anemia who are receiving chemotherapy.
    Quirt I; Robeson C; Lau CY; Kovacs M; Burdette-Radoux S; Dolan S; Tang SC; McKenzie M; Couture F;
    J Clin Oncol; 2001 Nov; 19(21):4126-34. PubMed ID: 11689580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparable efficacy of epoetin alfa for anemic cancer patients receiving platinum- and nonplatinum-based chemotherapy: a retrospective subanalysis of two large, community-based trials.
    Glaspy J; Degos L; Dicato M; Demetri GD
    Oncologist; 2002; 7(2):126-35. PubMed ID: 11961196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting the hematopoietic response to recombinant human erythropoietin (Epoetin alfa) in the treatment of the anemia of cancer.
    Adamson JW; Ludwig H
    Oncology; 1999; 56(1):46-53. PubMed ID: 9885377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: results of a randomized, double-blind, placebo-controlled trial.
    Littlewood TJ; Bajetta E; Nortier JW; Vercammen E; Rapoport B;
    J Clin Oncol; 2001 Jun; 19(11):2865-74. PubMed ID: 11387359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice. Procrit Study Group.
    Glaspy J; Bukowski R; Steinberg D; Taylor C; Tchekmedyian S; Vadhan-Raj S
    J Clin Oncol; 1997 Mar; 15(3):1218-34. PubMed ID: 9060566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The evolving role of epoetin alfa in cancer therapy.
    Henry DH
    Oncologist; 2004; 9(1):97-107. PubMed ID: 14755019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of epoetin alfa to increase and maintain hemoglobin levels during radiotherapy.
    Dunst J
    Semin Oncol; 2001 Apr; 28(2 Suppl 8):42-8. PubMed ID: 11395852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New insights into erythropoietin and epoetin alfa: mechanisms of action, target tissues, and clinical applications.
    Weiss MJ
    Oncologist; 2003; 8 Suppl 3():18-29. PubMed ID: 14671225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythropoietin, the biology of erythropoiesis and epoetin alfa. An overview.
    Bieber E
    J Reprod Med; 2001 May; 46(5 Suppl):521-30. PubMed ID: 11396386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epoetin alfa in cancer patients: evidence-based guidelines.
    Turner R; Anglin P; Burkes R; Couture F; Evans W; Goss G; Grimshaw R; Melosky B; Paterson A; Quirt I;
    J Pain Symptom Manage; 2001 Nov; 22(5):954-65. PubMed ID: 11728799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epoetin alfa for the treatment of cancer- and chemotherapy-related anaemia: product review and update.
    Henry DH
    Expert Opin Pharmacother; 2005 Feb; 6(2):295-310. PubMed ID: 15757425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical experience with epoetin alfa in the management of hemoglobin levels in orthopedic surgery and cancer. Implications for use in gynecologic surgery.
    Stovall TG
    J Reprod Med; 2001 May; 46(5 Suppl):531-8. PubMed ID: 11396387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of Epoetin alfa on quality of life in anemic cancer patients.
    Cella D; Bron D
    Cancer Pract; 1999; 7(4):177-82. PubMed ID: 10687582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Once weekly recombinant human erythropoietin treatment for cancer-induced anemia in children with acute lymphoblastic leukemia receiving maintenance chemotherapy: a randomized case-controlled study.
    Abdelrazik N; Fouda M
    Hematology; 2007 Dec; 12(6):533-41. PubMed ID: 17852440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Once-weekly epoetin alfa for treating the anemia of chronic kidney disease.
    Provenzano R; Garcia-Mayol L; Suchinda P; Von Hartitzsch B; Woollen SB; Zabaneh R; Fink JC;
    Clin Nephrol; 2004 Jun; 61(6):392-405. PubMed ID: 15224803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical evaluation of once-weekly dosing of epoetin alfa in chemotherapy patients: improvements in hemoglobin and quality of life are similar to three-times-weekly dosing.
    Gabrilove JL; Cleeland CS; Livingston RB; Sarokhan B; Winer E; Einhorn LH
    J Clin Oncol; 2001 Jun; 19(11):2875-82. PubMed ID: 11387360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epoetin alfa corrects anemia and improves quality of life in patients with hematologic malignancies receiving non-platinum chemotherapy.
    Littlewood TJ; Nortier J; Rapoport B; Pawlicki M; de Wasch G; Vercammen E; Schuette W; Wils J; Freund M;
    Hematol Oncol; 2003 Dec; 21(4):169-80. PubMed ID: 14735555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epoetin alfa improves quality of life in patients with cancer: results of metaanalysis.
    Jones M; Schenkel B; Just J; Fallowfield L
    Cancer; 2004 Oct; 101(8):1720-32. PubMed ID: 15386341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benefits associated with an early hemoglobin response to epoetin alfa therapy in the treatment of chemotherapy-related anemia.
    Campos SM; Duh MS; Lefebvre P; Rosberg J
    J Natl Compr Canc Netw; 2005 Nov; 3(6):807-16. PubMed ID: 16316616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.